Artia Global Partners’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-400,000
Closed -$57.6M 60
2025
Q3
$57.6M Buy
400,000
+360,000
+900% +$44.1M 9.13% 3
2025
Q2
$4.03M Buy
+40,000
New +$3.06M 0.97% 17

Other funds holding INSM

Artia Global Partners's INSM Position: Q1 2026 in Review

Artia Global Partners reduced its Insmed (INSM) stake by 7.8% in Q1 2026, selling an estimated $8.23M and leaving 628,712 shares worth $103M. The position accounts for 20.59% of the portfolio, ranked #1.

Artia Global Partners first reported a position in INSM in Q4 2023 and has held it in 10 quarters since. The position peaked at $119M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Artia Global Partners held 628,712 shares of Insmed worth $103M as of Q1 2026.
  • Artia Global Partners sold 53,500 Insmed shares in Q1 2026, an estimated $8.23M.
  • Insmed made up 20.59% of Artia Global Partners's portfolio in Q1 2026, its #1 holding.
  • Artia Global Partners first reported a position in Insmed in Q4 2023 and has held it in 10 quarters since.
  • Artia Global Partners's Insmed position peaked at $119M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Artia Global Partners's 13F filing for Q1 2026, filed 15 May 2026.